Whether miR93 plays a role in modulating cisplatin resistance in primary OvCa tumors remains to be determined, however our results suggest that loss of miR93 may modulate KIF14 mRNA overexpression in primary OvCa tumor cells to promote poor outcome. This evidence concerns the gene KIF14 and neoplasm.